Document Type : Original Article

Authors

1 Department of Genetics, Ahar Branch, Islamic Azad University, Ahar, Tabriz, Iran

2 Unit of Genomics Research, Digestive Diseases Research Center, Ardabil University of Medical Sciences, Ardabil, Iran

3 Department of community medicine, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran

Abstract

Background: Beta-thalassemia is one of the most common genetic diseases with autosomal recessive inherited patterns in the world and is one of the most common diseases in Iran that exists in all age and sex groups. Determining gene mutations in this disease can be effective in controlling and treating the disease. The present study determined the frequency of polymorphisms of Hinc, RSaI, RDB, and Xmn in patients with beta-thalassemia minor in Ardabil province. Methods: 53 beta-thalassemia patients referred to the genetic department of Imam Khomeini Hospital were studied. Blood samples were taken to determine the type of gene mutation. PCR samples were genetically evaluated to determine genetic mutations using RDB-Sequence-RFLP-Haplotype methods. Results: A total of 53 samples were examined, of which 56.6% were male and the rest were female. The most positive cases in the first and second ranks were related to XmnI and AvaII enzymes with 73.5% and 60.3%, respectively. The most common mutation extracted in the studied samples with 14 cases (26.4%) was IVS2.1. Among the most common mutations extracted by the RDB method was related to IVS 1.2 with 26.4%. Conclusions: The results of the present study showed that the distribution of genetic mutations in the studied samples can be different from other places. Also, by performing targeted genetic counseling, it is possible to control and prevent the disease in the future.

Graphical Abstract

Prevalence of RDB, RSa, Hinc and Xmn polymorphisms and HBBS11D haplotypes in patients with thalassemia minor

Keywords

Main Subjects

Selected author of this article by journal

ِDr. Firouz Amani
Ardabil University of Medical Sciences

GoogleScholar

Publons

Open Access

This article is licensed under a CC BY License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit: http://creativecommons.org/licenses/by/4.0/

 

Publisher’s Note

CMBR journal remains neutral with regard to jurisdictional claims in published maps and institutional afflictions.

 

Letters to Editor

Given that CMBR Journal's policy in accepting articles will be strict and will do its best to ensure that in addition to having the highest quality published articles, the published articles should have the least similarity (maximum 15%). Also, all the figures and tables in the article must be original and the copyright permission of images must be prepared by authors. However, some articles may have flaws and have passed the journal filter, which dear authors may find fault with. Therefore, the editor of the journal asks the authors, if they see an error in the published articles of the journal, to email the article information along with the documents to the journal office.

CMBR Journal welcomes letters to the editor ([email protected], [email protected]) for the post-publication discussions and corrections which allows debate post publication on its site, through the Letters to Editor. Critical letters can be sent to the journal editor as soon as the article is online. Following points are to be considering before sending the letters (comments) to the editor.

[1] Letters that include statements of statistics, facts, research, or theories should include appropriate references, although more than three are discouraged.

[2] Letters that are personal attacks on an author rather than thoughtful criticism of the author’s ideas will not be considered for publication.

[3] There is no limit to the number of words in a letter.

[4] Letter writers should include a statement at the beginning of the letter stating that it is being submitted either for publication or not.

[5] Anonymous letters will not be considered.

[6] Letter writers must include Name, Email Address, Affiliation, mobile phone number, and Comments.

[7] Letters will be answered as soon as possible.

  1. Azami M, Gheisoori A, Sayehmiri F, Sayehmiri K (2016) Prevalence of hypothyroidism in patients with Beta thalassemia major in Iran: A systematic review and meta-analysis. Scientific Journal of Kurdistan University of Medical Sciences 21(1):104-116. doi:http://dx.doi.org/10.22102/21.1.104
  2. Mahdavi MR, Hojjati MT, Roshan P (2013) A review on thalassemia and related complications. Journal of Mazandaran University of Medical Sciences 23(103):139-149
  3. Shiri R, Mahdieh N (2015) An overview on thalassemia: genetics of beta thalassemia in Iran. Koomesh 17(1):1-17. doi:Record Number : 20153363345
  4. Galanello R, Origa R (2010) Beta-thalassemia. Orphanet journal of rare diseases 5(1):1-15. doi:https://doi.org/10.1186/1750-1172-5-11
  5. Kadhim KA, Baldawi KH, Lami FH (2017) Prevalence, incidence, trend, and complications of thalassemia in Iraq. Hemoglobin 41(3):164-168. doi:https://doi.org/10.1080/03630269.2017.1354877
  6. Haghi M, Pouladi N, Hosseinpour Feizi M, Hosseinpour Feizi A (2010) Β-Thalassemia in Iran. SSU_Journals 18(2):127-133
  7. Abolghasemi H, Amid A, Zeinali S, Radfar MH, Eshghi P, Rahiminejad MS, Ehsani MA, Najmabadi H, Akbari MT, Afrasiabi A (2007) Thalassemia in Iran: epidemiology, prevention, and management. Journal of Pediatric Hematology/Oncology 29(4):233-238. doi:https://doi.org/10.1097/MPH.0b013e3180437e02
  8. Babashah S, Jamali S, Mahdian R, Nosaeid MH, Karimipoor M, Alimohammadi R, Raeisi M, Maryami F, Masoudifar M, Zeinali S (2009) Detection of unknown deletions in β‐globin gene cluster using relative quantitative PCR methods. European journal of haematology 83(3):261-269. doi:https://doi.org/10.1111/j.1600-0609.2009.01264.x
  9. Motovali-bashi M, Sajadpour Z, Ghasemi T (2016) Genetic diversity of HindIIIG polymorphism in second intron IVSII-I Gγ gene and its association with HbF level in β-thalassemia and intermedia thalassemia in Isfahan province. Scientific Journal of Iran Blood Transfus Organ 13(2):122-129
  10. Haghi M, Khorshidi S, Hosseinpour Feizi MA, Pouladi N, Hosseinpour Feizi AA (2009) β-Thalassemia mutations in the Iranian Kurdish population of Kurdistan and West Azerbaijan provinces. Hemoglobin 33(2):109-114. doi:https://doi.org/10.1080/03630260902862020
  11. Khatkar MS, Zenger KR, Hobbs M, Hawken RJ, Cavanagh JA, Barris W, McClintock AE, McClintock S, Thomson PC, Tier B (2007) A primary assembly of a bovine haplotype block map based on a 15,036-single-nucleotide polymorphism panel genotyped in Holstein–Friesian cattle. Genetics 176(2):763-772. doi:https://doi.org/10.1534/genetics.106.069369
  12. Yamamoto T, Nagasaki H, Yonemaru J-i, Ebana K, Nakajima M, Shibaya T, Yano M (2010) Fine definition of the pedigree haplotypes of closely related rice cultivars by means of genome-wide discovery of single-nucleotide polymorphisms. BMC genomics 11(1):1-14. doi:https://doi.org/10.1186/1471-2164-11-267
  13. Miri‐Moghaddam E, Zadeh‐Vakili A, Rouhani Z, Naderi M, Eshghi P, Khazaei Feizabad A (2011) Molecular basis and prenatal diagnosis of β‐thalassemia among Balouch population in Iran. Prenatal diagnosis 31(8):788-791. doi:https://doi.org/10.1002/pd.2767
  14. Kyriakou A, Savva SC, Savvides I, Pangalou E, Ioannou YS, Christou S, Skordis N (2008) Gender differences in the prevalence and severity of bone disease in thalassaemia. Pediatric Endocrinology Reviews: PER 6:116-122. doi:PMID: 19337164
  15. Cadeddu C, Franconi F, Cassisa L, Campesi I, Pepe A, Cugusi L, Maffei S, Gallina S, Sciomer S, Mercuro G (2016) Working Group of Gender Medicine of Italian Society of Cardiology. Arterial hypertension in the female world: pathophysiology and therapy J Cardiovasc Med (Hagerstown) 17:229-236
  16. Sirdah M, Al Mghari K, Abuzaid AH, Al Haddad RM (2018) Should sex differences be considered when applying mathematical indices and formulas for discriminating β-thalassemia minor from iron deficiency? Practical laboratory medicine 11:1-9. doi:https://doi.org/10.1016/j.plabm.2018.01.004
  17. Al-Ali Z, Faraj SH (2016) Prevalence of β-thalassemia Patients in Missan Province. GJBAHS 5(1):68-70
  18. Kosaryan M, Karami H, Darvishi-Khezri H, Akbarzadeh R, Aliasgharian A, Bromand K (2018) Demographic data of patients with β-thalassemia major recorded in the electronic system in the north of Iran, 2016. Tanzania Journal of Health Research 20(3):1-7. doi:https://doi.org/10.4314/thrb.v20i3.3
  19. Abbasalipour M, Khosravi MA, Zeinali S, Khanahmad H, Azadmanesh K, Karimipoor M (2022) Lentiviral vector containing beta-globin gene for beta thalassemia gene therapy. Gene Reports 27:101615. doi:https://doi.org/10.1016/j.genrep.2022.101615
  20. Alenzi FQ, AlShaya DS (2019) Biochemical and molecular analysis of the beta-globin gene on Saudi sickle cell anemia. Saudi Journal of Biological Sciences 26(7):1377-1384. doi:https://doi.org/10.1016/j.sjbs.2019.03.003
  21. Teh LK, Elizabeth G, Lai MI, Wong L, Ismail P (2018) Haplotype analysis of β-thalassaemia major and carriers with Filipino β-deletion in Sabah, Malaysia. The Malaysian Journal of Medical Sciences: MJMS 25(4):63-71. doi:https://doi.org/10.21315%2Fmjms2018.25.4.6
  22. Lee YJ, Park SS, Kim JY, Cho HI (2002) RFLP haplotypes of beta-globin gene complex of beta-thalassemic chromosomes in Koreans. Journal of Korean medical science 17(4):475-478. doi:https://doi.org/10.3346/jkms.2002.17.4.475
  23. Bahadır A, Öztürk O, Atalay A, Atalay EÖ (2009) Beta globin gene cluster haplotypes of the beta thalassemia mutations observed in the Denizli province of Turkey. Turk J Haematol 26(3):129-137. doi:PMID: 27265496
  24. Falchi A, Giovannoni L, Vacca L, Latini V, Vona G, Varesi L (2005) β‐Globin gene cluster haplotypes associated with β-thalassemia on Corsica Island. American journal of hematology 78(1):27-32. doi:https://doi.org/10.1002/ajh.20199
  25. Sajadpour Z, Amini-Farsani Z, Motovali-Bashi M, Yadollahi M, Yadollahi F (2019) Investigation of RFLP haplotypes β-globin gene cluster in beta-thalassemia patients in central Iran. International Journal of Hematology-Oncology and Stem Cell Research 13(2):61-67. doi:PMCID: PMC6660478; PMID: 31372199
  26. Saleh-Gohari N, Saeidi K, Ziaadini-Dashtkhaki S (2020) Haplotype Analysis in Carriers of β-Globin Gene Mutation Facilitates Genetic Counseling in β-Thalassemia: A Cross-Sectional Study in Kerman Province, Iran. Iranian Journal of Public Health 49(4):791-799. doi:PMCID: PMC7283172; PMID: 32548060